Mercury poisoning is serious public health issues caused due to consumption of mercury that leads to sudden illness and death. Most of the mercury toxicity comes naturally from the environment although the amount has been increased due to industrialization, coal combustion, and mining. The exposure to it and its inhalation may affect many parts of the body including central nervous system, digestive system, immune systems and others.
MARKET SCOPE
The "Global Mercury Poisoning Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the mercury poisoning treatment market with detailed market segmentation by forms, disease, drugs, treatment type, route of administration, end user, and geography. The report provides key statistics on the market status of the leading mercury poisoning treatment market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on forms, the global mercury poisoning treatment market is segmented into methyl mercury, elemental mercury and others.
- On the basis of disease, the market is bifurcated into acute mercury poisoning and chronic mercury poisoning.
- On the basis of drugs, the market is bifurcated into chelating agents, combination therapy with chelating agents and plasma exchange hemodialysis plasmapheresis.
- On the basis of treatment type, the market is bifurcated into supportive treatment and antidotal treatment.
- On the basis of route of administration, the market is segmented into injectable and oral.
- On the basis of end user, the market is bifurcated into hospitals, homecare, specialty clinics and others.
MARKET DYNAMICS
Drivers
- Growing number of mercury poisoning patients due to dental amalgams is driving the market growth.
- Emergence of treatment drugs used to cure complications like cardiovascular disorders associated with mercury poisoning boost the market growth.
- Increasing initiatives by healthcare professionals and government to protect patient from accidental mercury poisoning and increased level of mercury emissions fuel the market growth.
- Increasing research and development investment for developing novel intervention propel market growth.
Restraints
- Limited availability of medicinal treatment options
- Scarcity of trained personnel and stringent safety regulations.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The mercury poisoning treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the mercury poisoning treatment market in these regions.
IMPACT OF COVID-19 ON MERCURY POISONING TREATMENT MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. During COVID-19 outbreak, since mercury emissions are already prevalent in the environment, hospitals are in constant contact with local, state, and federal agencies in order to stay uncompromised to treat patients with mercury poisoning. Hospitals are adopting safety practices in situations where patients require emergency care. Companies in the mercury poisoning treatment market are increasing their production capabilities in drugs to avoid scarcity in medical supplies and to meet emergency case exposed to mercury during the COVID-19 situation. Manufacturers are increasing the availability of mercury-free alternatives for dental fillings in case of pediatric dental care emergency cases. Hence, the market is estimated to grow at a steady pace during the forecast period.
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The mercury poisoning treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the mercury poisoning treatment market in these regions.
IMPACT OF COVID-19 ON MERCURY POISONING TREATMENT MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. During COVID-19 outbreak, since mercury emissions are already prevalent in the environment, hospitals are in constant contact with local, state, and federal agencies in order to stay uncompromised to treat patients with mercury poisoning. Hospitals are adopting safety practices in situations where patients require emergency care. Companies in the mercury poisoning treatment market are increasing their production capabilities in drugs to avoid scarcity in medical supplies and to meet emergency case exposed to mercury during the COVID-19 situation. Manufacturers are increasing the availability of mercury-free alternatives for dental fillings in case of pediatric dental care emergency cases. Hence, the market is estimated to grow at a steady pace during the forecast period.
MARKET PLAYERS
The report covers key developments in the mercury poisoning treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from mercury poisoning treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for mercury poisoning treatment in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the mercury poisoning treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- EmeraMed
- Bausch Health
- Avalon Pharma
- CG Chemikalien GmbH & Co. KG
- Heyl Chemisch-pharmazeutische Fabrik GmbH Co. KG
- imprimisRx
- Genex Pharma
- Amerigen Pharmaceuticals Limited
- Teva Pharmaceutical Industries Ltd
- Mylan N.V.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Mercury Poisoning Treatment Market - By Forms
1.3.2 Mercury Poisoning Treatment Market - By Disease
1.3.3 Mercury Poisoning Treatment Market - By Drugs
1.3.4 Mercury Poisoning Treatment Market - By Treatment Type
1.3.5 Mercury Poisoning Treatment Market - By Routes of Administration
1.3.6 Mercury Poisoning Treatment Market - By End Users
1.3.7 Mercury Poisoning Treatment Market - By Region
1.3.7.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MERCURY POISONING TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. MERCURY POISONING TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MERCURY POISONING TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. MERCURY POISONING TREATMENT - GLOBAL MARKET OVERVIEW
6.2. MERCURY POISONING TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. MERCURY POISONING TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - FORMS
7.1. OVERVIEW
7.2. FORMS MARKET FORECASTS AND ANALYSIS
7.3. METHYL MERCURY
7.3.1. Overview
7.3.2. Methyl mercury Market Forecast and Analysis
7.4. ELEMENTAL MERCURY
7.4.1. Overview
7.4.2. Elemental Mercury Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. MERCURY POISONING TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE
8.1. OVERVIEW
8.2. DISEASE MARKET FORECASTS AND ANALYSIS
8.3. ACUTE MERCURY POISONING
8.3.1. Overview
8.3.2. Acute Mercury Poisoning Market Forecast and Analysis
8.4. CHRONIC MERCURY POISONING
8.4.1. Overview
8.4.2. Chronic Mercury Poisoning Market Forecast and Analysis
9. MERCURY POISONING TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DRUGS
9.1. OVERVIEW
9.2. DRUGS MARKET FORECASTS AND ANALYSIS
9.3. CHELATING AGENTS
9.3.1. Overview
9.3.2. Chelating Agents Market Forecast and Analysis
9.3.3. Dimercaprol or British anti-Lewisite (BAL) Market
9.3.3.1. Overview
9.3.3.2. Dimercaprol or British anti-Lewisite (BAL) Market Forecast and Analysis
9.3.4. Dimercaptosuccinic Acid (DMSA) Market
9.3.4.1. Overview
9.3.4.2. Dimercaptosuccinic Acid (DMSA) Market Forecast and Analysis
9.3.5. DMPS Market
9.3.5.1. Overview
9.3.5.2. DMPS Market Forecast and Analysis
9.3.6. Penicillamine Market
9.3.6.1. Overview
9.3.6.2. Penicillamine Market Forecast and Analysis
9.3.7. Others Market
9.3.7.1. Overview
9.3.7.2. Others Market Forecast and Analysis
9.4. COMBINATION THERAPY WITH CHELATING AGENTS
9.4.1. Overview
9.4.2. Combination Therapy with Chelating Agents Market Forecast and Analysis
9.5. PLASMA EXCHANGE HEMODIALYSIS PLASMAPHERESIS
9.5.1. Overview
9.5.2. Plasma Exchange Hemodialysis Plasmapheresis Market Forecast and Analysis
10. MERCURY POISONING TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
10.1. OVERVIEW
10.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
10.3. SUPPORTIVE TREATMENT
10.3.1. Overview
10.3.2. Supportive Treatment Market Forecast and Analysis
10.4. ANTIDOTAL TREATMENT
10.4.1. Overview
10.4.2. Antidotal Treatment Market Forecast and Analysis
11. MERCURY POISONING TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - ROUTES OF ADMINISTRATION
11.1. OVERVIEW
11.2. ROUTES OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
11.3. INJECTABLE
11.3.1. Overview
11.3.2. Injectable Market Forecast and Analysis
11.4. ORAL
11.4.1. Overview
11.4.2. Oral Market Forecast and Analysis
12. MERCURY POISONING TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - END USERS
12.1. OVERVIEW
12.2. END USERS MARKET FORECASTS AND ANALYSIS
12.3. HOSPITALS
12.3.1. Overview
12.3.2. Hospitals Market Forecast and Analysis
12.4. HOMECARE
12.4.1. Overview
12.4.2. Homecare Market Forecast and Analysis
12.5. SPECIALTY CLINICS
12.5.1. Overview
12.5.2. Specialty Clinics Market Forecast and Analysis
12.6. OTHERS
12.6.1. Overview
12.6.2. Others Market Forecast and Analysis
13. MERCURY POISONING TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
13.1. NORTH AMERICA
13.1.1 North America Mercury Poisoning Treatment Market Overview
13.1.2 North America Mercury Poisoning Treatment Market Forecasts and Analysis
13.1.3 North America Mercury Poisoning Treatment Market Forecasts and Analysis - By Forms
13.1.4 North America Mercury Poisoning Treatment Market Forecasts and Analysis - By Disease
13.1.5 North America Mercury Poisoning Treatment Market Forecasts and Analysis - By Drugs
13.1.6 North America Mercury Poisoning Treatment Market Forecasts and Analysis - By Treatment Type
13.1.7 North America Mercury Poisoning Treatment Market Forecasts and Analysis - By Routes of Administration
13.1.8 North America Mercury Poisoning Treatment Market Forecasts and Analysis - By End Users
13.1.9 North America Mercury Poisoning Treatment Market Forecasts and Analysis - By Countries
13.1.9.1 Canada Mercury Poisoning Treatment Market
13.1.9.1.1 Canada Mercury Poisoning Treatment Market by Forms
13.1.9.1.2 Canada Mercury Poisoning Treatment Market by Disease
13.1.9.1.3 Canada Mercury Poisoning Treatment Market by Drugs
13.1.9.1.4 Canada Mercury Poisoning Treatment Market by Treatment Type
13.1.9.1.5 Canada Mercury Poisoning Treatment Market by Routes of Administration
13.1.9.1.6 Canada Mercury Poisoning Treatment Market by End Users
13.1.9.2 Mexico Mercury Poisoning Treatment Market
13.1.9.2.1 Mexico Mercury Poisoning Treatment Market by Forms
13.1.9.2.2 Mexico Mercury Poisoning Treatment Market by Disease
13.1.9.2.3 Mexico Mercury Poisoning Treatment Market by Drugs
13.1.9.2.4 Mexico Mercury Poisoning Treatment Market by Treatment Type
13.1.9.2.5 Mexico Mercury Poisoning Treatment Market by Routes of Administration
13.1.9.2.6 Mexico Mercury Poisoning Treatment Market by End Users
13.1.9.3 US Mercury Poisoning Treatment Market
13.1.9.3.1 US Mercury Poisoning Treatment Market by Forms
13.1.9.3.2 US Mercury Poisoning Treatment Market by Disease
13.1.9.3.3 US Mercury Poisoning Treatment Market by Drugs
13.1.9.3.4 US Mercury Poisoning Treatment Market by Treatment Type
13.1.9.3.5 US Mercury Poisoning Treatment Market by Routes of Administration
13.1.9.3.6 US Mercury Poisoning Treatment Market by End Users
13.2. EUROPE
13.2.1 Europe Mercury Poisoning Treatment Market Overview
13.2.2 Europe Mercury Poisoning Treatment Market Forecasts and Analysis
13.2.3 Europe Mercury Poisoning Treatment Market Forecasts and Analysis - By Forms
13.2.4 Europe Mercury Poisoning Treatment Market Forecasts and Analysis - By Disease
13.2.5 Europe Mercury Poisoning Treatment Market Forecasts and Analysis - By Drugs
13.2.6 Europe Mercury Poisoning Treatment Market Forecasts and Analysis - By Treatment Type
13.2.7 Europe Mercury Poisoning Treatment Market Forecasts and Analysis - By Routes of Administration
13.2.8 Europe Mercury Poisoning Treatment Market Forecasts and Analysis - By End Users
13.2.9 Europe Mercury Poisoning Treatment Market Forecasts and Analysis - By Countries
13.2.9.1 Germany Mercury Poisoning Treatment Market
13.2.9.1.1 Germany Mercury Poisoning Treatment Market by Forms
13.2.9.1.2 Germany Mercury Poisoning Treatment Market by Disease
13.2.9.1.3 Germany Mercury Poisoning Treatment Market by Drugs
13.2.9.1.4 Germany Mercury Poisoning Treatment Market by Treatment Type
13.2.9.1.5 Germany Mercury Poisoning Treatment Market by Routes of Administration
13.2.9.1.6 Germany Mercury Poisoning Treatment Market by End Users
13.2.9.2 France Mercury Poisoning Treatment Market
13.2.9.2.1 France Mercury Poisoning Treatment Market by Forms
13.2.9.2.2 France Mercury Poisoning Treatment Market by Disease
13.2.9.2.3 France Mercury Poisoning Treatment Market by Drugs
13.2.9.2.4 France Mercury Poisoning Treatment Market by Treatment Type
13.2.9.2.5 France Mercury Poisoning Treatment Market by Routes of Administration
13.2.9.2.6 France Mercury Poisoning Treatment Market by End Users
13.2.9.3 Italy Mercury Poisoning Treatment Market
13.2.9.3.1 Italy Mercury Poisoning Treatment Market by Forms
13.2.9.3.2 Italy Mercury Poisoning Treatment Market by Disease
13.2.9.3.3 Italy Mercury Poisoning Treatment Market by Drugs
13.2.9.3.4 Italy Mercury Poisoning Treatment Market by Treatment Type
13.2.9.3.5 Italy Mercury Poisoning Treatment Market by Routes of Administration
13.2.9.3.6 Italy Mercury Poisoning Treatment Market by End Users
13.2.9.4 Spain Mercury Poisoning Treatment Market
13.2.9.4.1 Spain Mercury Poisoning Treatment Market by Forms
13.2.9.4.2 Spain Mercury Poisoning Treatment Market by Disease
13.2.9.4.3 Spain Mercury Poisoning Treatment Market by Drugs
13.2.9.4.4 Spain Mercury Poisoning Treatment Market by Treatment Type
13.2.9.4.5 Spain Mercury Poisoning Treatment Market by Routes of Administration
13.2.9.4.6 Spain Mercury Poisoning Treatment Market by End Users
13.2.9.5 United Kingdom Mercury Poisoning Treatment Market
13.2.9.5.1 United Kingdom Mercury Poisoning Treatment Market by Forms
13.2.9.5.2 United Kingdom Mercury Poisoning Treatment Market by Disease
13.2.9.5.3 United Kingdom Mercury Poisoning Treatment Market by Drugs
13.2.9.5.4 United Kingdom Mercury Poisoning Treatment Market by Treatment Type
13.2.9.5.5 United Kingdom Mercury Poisoning Treatment Market by Routes of Administration
13.2.9.5.6 United Kingdom Mercury Poisoning Treatment Market by End Users
13.2.9.6 Rest of Europe Mercury Poisoning Treatment Market
13.2.9.6.1 Rest of Europe Mercury Poisoning Treatment Market by Forms
13.2.9.6.2 Rest of Europe Mercury Poisoning Treatment Market by Disease
13.2.9.6.3 Rest of Europe Mercury Poisoning Treatment Market by Drugs
13.2.9.6.4 Rest of Europe Mercury Poisoning Treatment Market by Treatment Type
13.2.9.6.5 Rest of Europe Mercury Poisoning Treatment Market by Routes of Administration
13.2.9.6.6 Rest of Europe Mercury Poisoning Treatment Market by End Users
13.3. ASIA-PACIFIC
13.3.1 Asia-Pacific Mercury Poisoning Treatment Market Overview
13.3.2 Asia-Pacific Mercury Poisoning Treatment Market Forecasts and Analysis
13.3.3 Asia-Pacific Mercury Poisoning Treatment Market Forecasts and Analysis - By Forms
13.3.4 Asia-Pacific Mercury Poisoning Treatment Market Forecasts and Analysis - By Disease
13.3.5 Asia-Pacific Mercury Poisoning Treatment Market Forecasts and Analysis - By Drugs
13.3.6 Asia-Pacific Mercury Poisoning Treatment Market Forecasts and Analysis - By Treatment Type
13.3.7 Asia-Pacific Mercury Poisoning Treatment Market Forecasts and Analysis - By Routes of Administration
13.3.8 Asia-Pacific Mercury Poisoning Treatment Market Forecasts and Analysis - By End Users
13.3.9 Asia-Pacific Mercury Poisoning Treatment Market Forecasts and Analysis - By Countries
13.3.9.1 Australia Mercury Poisoning Treatment Market
13.3.9.1.1 Australia Mercury Poisoning Treatment Market by Forms
13.3.9.1.2 Australia Mercury Poisoning Treatment Market by Disease
13.3.9.1.3 Australia Mercury Poisoning Treatment Market by Drugs
13.3.9.1.4 Australia Mercury Poisoning Treatment Market by Treatment Type
13.3.9.1.5 Australia Mercury Poisoning Treatment Market by Routes of Administration
13.3.9.1.6 Australia Mercury Poisoning Treatment Market by End Users
13.3.9.2 China Mercury Poisoning Treatment Market
13.3.9.2.1 China Mercury Poisoning Treatment Market by Forms
13.3.9.2.2 China Mercury Poisoning Treatment Market by Disease
13.3.9.2.3 China Mercury Poisoning Treatment Market by Drugs
13.3.9.2.4 China Mercury Poisoning Treatment Market by Treatment Type
13.3.9.2.5 China Mercury Poisoning Treatment Market by Routes of Administration
13.3.9.2.6 China Mercury Poisoning Treatment Market by End Users
13.3.9.3 India Mercury Poisoning Treatment Market
13.3.9.3.1 India Mercury Poisoning Treatment Market by Forms
13.3.9.3.2 India Mercury Poisoning Treatment Market by Disease
13.3.9.3.3 India Mercury Poisoning Treatment Market by Drugs
13.3.9.3.4 India Mercury Poisoning Treatment Market by Treatment Type
13.3.9.3.5 India Mercury Poisoning Treatment Market by Routes of Administration
13.3.9.3.6 India Mercury Poisoning Treatment Market by End Users
13.3.9.4 Japan Mercury Poisoning Treatment Market
13.3.9.4.1 Japan Mercury Poisoning Treatment Market by Forms
13.3.9.4.2 Japan Mercury Poisoning Treatment Market by Disease
13.3.9.4.3 Japan Mercury Poisoning Treatment Market by Drugs
13.3.9.4.4 Japan Mercury Poisoning Treatment Market by Treatment Type
13.3.9.4.5 Japan Mercury Poisoning Treatment Market by Routes of Administration
13.3.9.4.6 Japan Mercury Poisoning Treatment Market by End Users
13.3.9.5 South Korea Mercury Poisoning Treatment Market
13.3.9.5.1 South Korea Mercury Poisoning Treatment Market by Forms
13.3.9.5.2 South Korea Mercury Poisoning Treatment Market by Disease
13.3.9.5.3 South Korea Mercury Poisoning Treatment Market by Drugs
13.3.9.5.4 South Korea Mercury Poisoning Treatment Market by Treatment Type
13.3.9.5.5 South Korea Mercury Poisoning Treatment Market by Routes of Administration
13.3.9.5.6 South Korea Mercury Poisoning Treatment Market by End Users
13.3.9.6 Rest of Asia-Pacific Mercury Poisoning Treatment Market
13.3.9.6.1 Rest of Asia-Pacific Mercury Poisoning Treatment Market by Forms
13.3.9.6.2 Rest of Asia-Pacific Mercury Poisoning Treatment Market by Disease
13.3.9.6.3 Rest of Asia-Pacific Mercury Poisoning Treatment Market by Drugs
13.3.9.6.4 Rest of Asia-Pacific Mercury Poisoning Treatment Market by Treatment Type
13.3.9.6.5 Rest of Asia-Pacific Mercury Poisoning Treatment Market by Routes of Administration
13.3.9.6.6 Rest of Asia-Pacific Mercury Poisoning Treatment Market by End Users
13.4. MIDDLE EAST AND AFRICA
13.4.1 Middle East and Africa Mercury Poisoning Treatment Market Overview
13.4.2 Middle East and Africa Mercury Poisoning Treatment Market Forecasts and Analysis
13.4.3 Middle East and Africa Mercury Poisoning Treatment Market Forecasts and Analysis - By Forms
13.4.4 Middle East and Africa Mercury Poisoning Treatment Market Forecasts and Analysis - By Disease
13.4.5 Middle East and Africa Mercury Poisoning Treatment Market Forecasts and Analysis - By Drugs
13.4.6 Middle East and Africa Mercury Poisoning Treatment Market Forecasts and Analysis - By Treatment Type
13.4.7 Middle East and Africa Mercury Poisoning Treatment Market Forecasts and Analysis - By Routes of Administration
13.4.8 Middle East and Africa Mercury Poisoning Treatment Market Forecasts and Analysis - By End Users
13.4.9 Middle East and Africa Mercury Poisoning Treatment Market Forecasts and Analysis - By Countries
13.4.9.1 South Africa Mercury Poisoning Treatment Market
13.4.9.1.1 South Africa Mercury Poisoning Treatment Market by Forms
13.4.9.1.2 South Africa Mercury Poisoning Treatment Market by Disease
13.4.9.1.3 South Africa Mercury Poisoning Treatment Market by Drugs
13.4.9.1.4 South Africa Mercury Poisoning Treatment Market by Treatment Type
13.4.9.1.5 South Africa Mercury Poisoning Treatment Market by Routes of Administration
13.4.9.1.6 South Africa Mercury Poisoning Treatment Market by End Users
13.4.9.2 Saudi Arabia Mercury Poisoning Treatment Market
13.4.9.2.1 Saudi Arabia Mercury Poisoning Treatment Market by Forms
13.4.9.2.2 Saudi Arabia Mercury Poisoning Treatment Market by Disease
13.4.9.2.3 Saudi Arabia Mercury Poisoning Treatment Market by Drugs
13.4.9.2.4 Saudi Arabia Mercury Poisoning Treatment Market by Treatment Type
13.4.9.2.5 Saudi Arabia Mercury Poisoning Treatment Market by Routes of Administration
13.4.9.2.6 Saudi Arabia Mercury Poisoning Treatment Market by End Users
13.4.9.3 U.A.E Mercury Poisoning Treatment Market
13.4.9.3.1 U.A.E Mercury Poisoning Treatment Market by Forms
13.4.9.3.2 U.A.E Mercury Poisoning Treatment Market by Disease
13.4.9.3.3 U.A.E Mercury Poisoning Treatment Market by Drugs
13.4.9.3.4 U.A.E Mercury Poisoning Treatment Market by Treatment Type
13.4.9.3.5 U.A.E Mercury Poisoning Treatment Market by Routes of Administration
13.4.9.3.6 U.A.E Mercury Poisoning Treatment Market by End Users
13.4.9.4 Rest of Middle East and Africa Mercury Poisoning Treatment Market
13.4.9.4.1 Rest of Middle East and Africa Mercury Poisoning Treatment Market by Forms
13.4.9.4.2 Rest of Middle East and Africa Mercury Poisoning Treatment Market by Disease
13.4.9.4.3 Rest of Middle East and Africa Mercury Poisoning Treatment Market by Drugs
13.4.9.4.4 Rest of Middle East and Africa Mercury Poisoning Treatment Market by Treatment Type
13.4.9.4.5 Rest of Middle East and Africa Mercury Poisoning Treatment Market by Routes of Administration
13.4.9.4.6 Rest of Middle East and Africa Mercury Poisoning Treatment Market by End Users
13.5. SOUTH AND CENTRAL AMERICA
13.5.1 South and Central America Mercury Poisoning Treatment Market Overview
13.5.2 South and Central America Mercury Poisoning Treatment Market Forecasts and Analysis
13.5.3 South and Central America Mercury Poisoning Treatment Market Forecasts and Analysis - By Forms
13.5.4 South and Central America Mercury Poisoning Treatment Market Forecasts and Analysis - By Disease
13.5.5 South and Central America Mercury Poisoning Treatment Market Forecasts and Analysis - By Drugs
13.5.6 South and Central America Mercury Poisoning Treatment Market Forecasts and Analysis - By Treatment Type
13.5.7 South and Central America Mercury Poisoning Treatment Market Forecasts and Analysis - By Routes of Administration
13.5.8 South and Central America Mercury Poisoning Treatment Market Forecasts and Analysis - By End Users
13.5.9 South and Central America Mercury Poisoning Treatment Market Forecasts and Analysis - By Countries
13.5.9.1 Brazil Mercury Poisoning Treatment Market
13.5.9.1.1 Brazil Mercury Poisoning Treatment Market by Forms
13.5.9.1.2 Brazil Mercury Poisoning Treatment Market by Disease
13.5.9.1.3 Brazil Mercury Poisoning Treatment Market by Drugs
13.5.9.1.4 Brazil Mercury Poisoning Treatment Market by Treatment Type
13.5.9.1.5 Brazil Mercury Poisoning Treatment Market by Routes of Administration
13.5.9.1.6 Brazil Mercury Poisoning Treatment Market by End Users
13.5.9.2 Argentina Mercury Poisoning Treatment Market
13.5.9.2.1 Argentina Mercury Poisoning Treatment Market by Forms
13.5.9.2.2 Argentina Mercury Poisoning Treatment Market by Disease
13.5.9.2.3 Argentina Mercury Poisoning Treatment Market by Drugs
13.5.9.2.4 Argentina Mercury Poisoning Treatment Market by Treatment Type
13.5.9.2.5 Argentina Mercury Poisoning Treatment Market by Routes of Administration
13.5.9.2.6 Argentina Mercury Poisoning Treatment Market by End Users
13.5.9.3 Rest of South and Central America Mercury Poisoning Treatment Market
13.5.9.3.1 Rest of South and Central America Mercury Poisoning Treatment Market by Forms
13.5.9.3.2 Rest of South and Central America Mercury Poisoning Treatment Market by Disease
13.5.9.3.3 Rest of South and Central America Mercury Poisoning Treatment Market by Drugs
13.5.9.3.4 Rest of South and Central America Mercury Poisoning Treatment Market by Treatment Type
13.5.9.3.5 Rest of South and Central America Mercury Poisoning Treatment Market by Routes of Administration
13.5.9.3.6 Rest of South and Central America Mercury Poisoning Treatment Market by End Users
14. INDUSTRY LANDSCAPE
14.1. MERGERS AND ACQUISITIONS
14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
14.3. NEW PRODUCT LAUNCHES
14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
15. MERCURY POISONING TREATMENT MARKET, KEY COMPANY PROFILES
15.1. EMERAMED
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Products and Services
15.1.4. Financial Overview
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. BAUSCH HEALTH
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Products and Services
15.2.4. Financial Overview
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. AVALON PHARMA
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Products and Services
15.3.4. Financial Overview
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. CG CHEMIKALIEN GMBH AND CO. KG
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Products and Services
15.4.4. Financial Overview
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. HEYL CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH CO. KG
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Products and Services
15.5.4. Financial Overview
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. IMPRIMISRX
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Products and Services
15.6.4. Financial Overview
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. GENEX PHARMA
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Products and Services
15.7.4. Financial Overview
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. AMERIGEN PHARMACEUTICALS LIMITED
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Products and Services
15.8.4. Financial Overview
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. TEVA PHARMACEUTICAL INDUSTRIES LTD
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Products and Services
15.9.4. Financial Overview
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. MYLAN N.V.
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Products and Services
15.10.4. Financial Overview
15.10.5. SWOT Analysis
15.10.6. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
1. EmeraMed
2. Bausch Health
3. Avalon Pharma
4. CG Chemikalien GmbH and Co. KG
5. Heyl Chemisch-pharmazeutische Fabrik GmbH Co. KG
6. imprimisRx
7. Genex Pharma
8. Amerigen Pharmaceuticals Limited
9. Teva Pharmaceutical Industries Ltd
10. Mylan N.V.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Mercury Poisoning Treatment Market
Apr 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2024
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)